Werner Klein

16.6k total citations · 1 hit paper
124 papers, 6.9k citations indexed

About

Werner Klein is a scholar working on Cardiology and Cardiovascular Medicine, Pollution and Surgery. According to data from OpenAlex, Werner Klein has authored 124 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cardiology and Cardiovascular Medicine, 18 papers in Pollution and 16 papers in Surgery. Recurrent topics in Werner Klein's work include Pesticide and Herbicide Environmental Studies (16 papers), Cardiovascular and exercise physiology (12 papers) and Cardiac Imaging and Diagnostics (11 papers). Werner Klein is often cited by papers focused on Pesticide and Herbicide Environmental Studies (16 papers), Cardiovascular and exercise physiology (12 papers) and Cardiac Imaging and Diagnostics (11 papers). Werner Klein collaborates with scholars based in Austria, Germany and United States. Werner Klein's co-authors include Lars Rydén, José Luis López Sendón, Michał Tendera, Jean‐Pierre Bassand, Magnus Öhman, Maarten L. Simoons, Elliott M. Antman, F. Körte, Friedrich Fruhwald and José López‐Sendón and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Werner Klein

119 papers receiving 6.5k citations

Hit Papers

Myocardial infarction redefined—a consensus document of T... 2000 2026 2008 2017 2000 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Werner Klein Austria 30 4.6k 1.7k 1.5k 570 440 124 6.9k
Heidi T. May United States 43 3.3k 0.7× 521 0.3× 1.2k 0.8× 410 0.7× 219 0.5× 207 7.5k
Fiona E. Strachan United Kingdom 30 2.3k 0.5× 833 0.5× 733 0.5× 283 0.5× 115 0.3× 67 4.2k
Barbara V. Howard United States 44 3.1k 0.7× 548 0.3× 1.8k 1.2× 1.2k 2.0× 184 0.4× 102 7.8k
Gervasio A. Lamas United States 54 15.8k 3.4× 2.4k 1.4× 4.5k 3.1× 921 1.6× 273 0.6× 252 19.1k
Melvyn Rubenfire United States 41 4.3k 0.9× 862 0.5× 1.4k 1.0× 302 0.5× 147 0.3× 229 7.5k
Roberto Elosúa Spain 63 5.9k 1.3× 892 0.5× 2.3k 1.6× 1.4k 2.4× 224 0.5× 370 13.8k
Benjamin D. Horne United States 56 4.2k 0.9× 493 0.3× 3.0k 2.0× 1.1k 2.0× 468 1.1× 321 11.9k
Peter M. Schofield United Kingdom 35 2.1k 0.5× 1.0k 0.6× 1.9k 1.3× 1.6k 2.8× 138 0.3× 114 6.9k
Elaine Hoffman United States 38 4.5k 1.0× 601 0.4× 1.9k 1.3× 1.3k 2.2× 1.3k 3.0× 64 10.6k
Gian Cesare Guidi Italy 50 1.5k 0.3× 332 0.2× 1.5k 1.0× 1.0k 1.8× 656 1.5× 358 11.1k

Countries citing papers authored by Werner Klein

Since Specialization
Citations

This map shows the geographic impact of Werner Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Klein more than expected).

Fields of papers citing papers by Werner Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Klein. The network helps show where Werner Klein may publish in the future.

Co-authorship network of co-authors of Werner Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Klein. A scholar is included among the top collaborators of Werner Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Klein. Werner Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fruhwald, Friedrich, Peter Rehak, Robert Maier, et al.. (2004). Austrian Survey of Treating Heart Failure—AUSTRIA. European Journal of Heart Failure. 6(7). 947–952. 7 indexed citations
2.
Stoschitzky, Kurt, et al.. (2004). Different Effects of Exercise on Plasma Concentrations of Nebivolol, Bisoprolol and Carvedilol. Cardiovascular Drugs and Therapy. 18(2). 135–138. 15 indexed citations
4.
Stoschitzky, Kurt, et al.. (2003). Long-term therapy with nebivolol does not cause nitrate tolerance. Journal of the American College of Cardiology. 41(6). 237–237.
6.
Furman, Mark I., Joel M. Gore, Andrzej Budaj, et al.. (2003). Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). American Heart Journal. 147(1). 42–48. 89 indexed citations
7.
Klein, Werner, Philippe Gabríel Steg, Andrzej Budaj, et al.. (2002). Improved survival and reduced bleeding with low-molecular-weight heparin across all acute coronary syndrome subsets: findings from the global registry of acute coronary events. Journal of the American College of Cardiology. 39. 444–444. 3 indexed citations
8.
Stoschitzky, Kurt, et al.. (2002). Unpredicted Lack of Effect of Exercise on Plasma Concentrations of Carvedilol. Journal of Cardiovascular Pharmacology. 39(1). 58–60. 8 indexed citations
9.
Dauerman, Harold L., Robert J. Goldberg, Werner Klein, et al.. (2002). Approach after thrombolytic therapy: invasive versus conservative management: global registry of acute coronary events. Journal of the American College of Cardiology. 39. 303–304. 2 indexed citations
10.
Berns, Anne E., et al.. (2002). Investigations on the binding mechanism of the herbicide simazine to dissolved organic matter in leachates of compost. Chemosphere. 49(6). 597–604. 20 indexed citations
11.
Klein, Werner, et al.. (2001). Diagnosis and Risk Stratification in Patients With Acute Coronary Syndromes According to ESC Guidelines. Thrombosis Research. 103. S57–S61. 2 indexed citations
12.
Antman, Elliott M., Jean‐Pierre Bassand, Werner Klein, et al.. (2000). Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology. 36(3). 959–969. 3778 indexed citations breakdown →
13.
Klein, Werner, Arnd B. Buchwald, W S Hillis, et al.. (1997). Fragmin in Unstable Angina Pectoris or in Non-Q-Wave Acute Myocardial Infarction (the FRIC Study). The American Journal of Cardiology. 80(5). 30E–34E. 28 indexed citations
14.
Schumacher, Martin, G. Halwachs, Franz Tatzber, et al.. (1997). Increased Neopterin in Patients With Chronic and Acute Coronary Syndromes. Journal of the American College of Cardiology. 30(3). 703–707. 93 indexed citations
15.
Dobnig, Harald, G. Leb, Rainer W. Lipp, et al.. (1995). Sulfoconjugated and free plasma catecholamine levels at rest and during exercise in patients with idiopathic dilated cardiomyopathy. European Journal of Endocrinology. 132(2). 181–191. 6 indexed citations
16.
Eber, Bernd, Franz Tatzber, Philipp A. Kaufmann, et al.. (1995). Transient reduction of autoantibodies against oxidized ldl in patients with acute myocardial infarction. Free Radical Biology and Medicine. 18(6). 1087–1091. 44 indexed citations
17.
Eber, Bernd, Martin Schumacher, Franz Tatzber, et al.. (1994). Autoantibodies to Oxidized Low Density Lipoproteins in Restenosis following Coronary Angioplasty. Cardiology. 84(4-5). 310–315. 27 indexed citations
19.
Klein, Werner, et al.. (1992). Frequency of magnetic resonance signal abnormalities of the brain in patients aged <50 years with idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 69(17). 1446–1450. 8 indexed citations
20.
Stoschitzky, Kurt, Werner Klein, Gerhard Stärk, et al.. (1990). Different stereoselective effects of (R)- and (S)-propafenone: Clinical pharmacologic, electrophysiologic, and radioligand binding studies. Clinical Pharmacology & Therapeutics. 47(6). 740–746. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026